Loading...
Loading...
Contributors:
Dataset URI:
10.6084/m9.figshare.30891155.v1This study investigated the relationship between the platelet-to-high-density lipoprotein cholesterol ratio (PHR) and chronic kidney disease (CKD) in a hypertensive population, exploring its mediating role in the obesity–CKD association. Using data from the National Health and Nutrition Examination Survey (NHANES) 2009–2018 on 10,467 hypertensive adults, we observed a complex association. Overall, PHR was positively correlated with CKD (odds ratio [OR] = 1.08, 95% CI: 1.05–1.14). However, the relationship was nonlinear and U-shaped, with an inflection point at a PHR Z-score of −0.32 (PHR = 166). Below this point, the association was negative (OR = 0.78, 95% CI: 0.65–0.91), whereas above it, the association was strongly positive (OR = 1.24, 95% CI: 1.15–1.36), particularly among individuals with obesity (BMI ≥ 30 kg/m2). Furthermore, PHR significantly mediated the relationship between obesity and CKD, accounting for 21.46% of the effect from BMI and 18.01% from waist circumference. In conclusion, PHR exhibits a U-shaped relationship with CKD in hypertensive individuals, most prominently in those with obesity, and may serve as an accessible biomarker of obesity-related inflammation for CKD risk stratification.
Keyword(s):
Cell Biology; Chronic kidney disease; hypertension; Immunology; Marine Biology.
MeSH Term(s):
Grants and Funding:
Associated Publication(s):
Supplementary Data:
No Supplementary Data Available
Related Dataset(s):
No Related Dataset Data Available
The National Library of Medicine (NLM) provides information about biomedical datasets. Inclusion on an NLM Web page does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. Learn more: NLM Web Policies (nih.gov)